Advantage Alpha Capital Partners LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 286 filers reported holding HAEMONETICS CORP in Q2 2020. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Advantage Alpha Capital Partners LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2020$4,339,000
-45.5%
36,536
-60.0%
0.95%
-48.4%
Q3 2020$7,961,000
-11.3%
91,246
-8.9%
1.84%
-12.4%
Q2 2020$8,971,000
+248.7%
100,170
+288.0%
2.10%
+129.0%
Q1 2020$2,573,00025,8180.92%
Other shareholders
HAEMONETICS CORP shareholders Q2 2020
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders